• Bradford S Hoppe, Stella Flampouri, Zhong Su, Naeem Latif, Nam H Dang, James Lynch, Michael Joyce, Eric Sandler, Zuofeng Li, and Nancy P Mendenhall.
• Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, FL 32206, USA. bhoppe@floridaproton.org
• Int. J. Radiat. Oncol. Biol. Phys. 2012 Oct 1; 84 (2): 449-55.

PurposeWe investigated the dosimetric impact of proton therapy (PT) on various cardiac subunits in patients with Hodgkin lymphoma (HL).Methods And MaterialsFrom June 2009 through December 2010, 13 patients were enrolled on an institutional review board-approved protocol for consolidative involved-node radiotherapy (INRT) for HL. Three separate treatment plans were developed prospectively by using three-dimensional conformal radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT), and PT. Cardiac subunits were retrospectively contoured on the 11 patients with intravenous-contrast simulation scans, and the doses were calculated for all treatment plans. A Wilcoxon paired test was performed to evaluate the statistical significance (p < 0.05) of 3DCRT and IMRT compared with PT.ResultsThe mean heart doses were 21 Gy, 12 Gy, and 8 Gy (relative biologic effectiveness [RBE]) with 3DCRT, IMRT, and PT, respectively. Compared with 3DCRT and IMRT, PT reduced the mean doses to the left and right atria; the left and right ventricles; the aortic, mitral, and tricuspid valves; and the left anterior descending, left circumflex, and right circumflex coronary arteries.ConclusionsCompared with 3DCRT and IMRT, PT reduced the radiation doses to all major cardiac subunits. Limiting the doses to these structures should translate into lower rates of cardiac toxicities.Copyright © 2012 Elsevier Inc. All rights reserved.

33 keywords...

hide…